Protease inhibitors in HIV infection - Lipodystrophy may be a consequence of prolonged survival

被引：11

作者：

Buss, N ^{[1
]}

Duff, F

机构：

[1] F Hoffmann La Roche & Co Ltd, CH-1070 Basel, Switzerland

[2] Roche Biomed Labs, Nutley, NJ USA

来源：

BRITISH MEDICAL JOURNAL | 1999年 / 318卷 / 7176期

关键词：

D O I：

10.1136/bmj.318.7176.122

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：122 / 122

页数：1

相关论文

共 5 条

[1] Protease inhibitors may cause fat abnormalities and heart disease
Berger, A
[J]. BRITISH MEDICAL JOURNAL, 1998, 317 (7151) : 100 - 100
[2] A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
Carr, A
Samaras, K
Burton, S
Law, M
Freund, J
Chisholm, DJ
Cooper, DA
[J]. AIDS, 1998, 12 (07) : F51 - F58
[3] Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
Carr, A
Samaras, K
Chisholm, DJ
Cooper, DA
[J]. LANCET, 1998, 351 (9119) : 1881 - 1883
[4] KOTLER DP, 1998, 12 WORLD AIDS C 28 J
[5] Buffalo hump in men with HIV-1 infection
Lo, JC
Mulligan, K
Tai, VW
Algren, H
Schambelan, M
[J]. LANCET, 1998, 351 (9106) : 867 - 870